Martingale Asset Management L P Abbott Laboratories Transaction History

Martingale Asset Management L P

$4.27 Billion
Q3 2024

A detailed history of Martingale Asset Management L P transactions in Abbott Laboratories stock. As of the latest transaction made, Martingale Asset Management L P holds 291,419 shares of ABT stock, worth $32.8 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

291,419

Previous 344,039 15.29%

Holding current value

$32.8 Million

Previous $35.7 Million 7.06%

% of portfolio

0.78%

Previous 0.78%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $5.27 Million - $6.22 Million	-52,620 Reduced 15.29%	291,419 $33.2 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $4.42 Million - $4.93 Million	-43,840 Reduced 11.3%	344,039 $35.7 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $3.25 Million - $3.59 Million	-29,709 Reduced 7.11%	387,879 $44.1 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $2.96 Million - $3.62 Million	-32,834 Reduced 7.29%	417,588 $46 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.4 Million - $1.67 Million	-14,608 Reduced 3.14%	450,422 $43.6 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $1.01 Million - $1.13 Million	-10,021 Reduced 2.11%	465,030 $50.7 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $62,280 - $73,308	643 Added 0.14%	475,051 $48.1 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $3.2 Million - $3.75 Million	-33,658 Reduced 6.62%	474,408 $52.1 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $235,223 - $272,344	-2,431 Reduced 0.48%	508,066 $49.2 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $3.3 Million - $3.98 Million	-32,287 Reduced 5.95%	510,497 $55.5 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $5.89 Million - $7.19 Million	-51,682 Reduced 8.69%	542,784 $64.2 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $4.49 Million - $5.5 Million	-38,901 Reduced 6.14%	594,466 $83.7 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $13.5 Million - $14.9 Million	-115,500 Reduced 15.42%	633,367 $74.8 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $4.22 Million - $4.97 Million	-39,872 Reduced 5.06%	748,867 $86.8 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $5.4 Million - $6.36 Million	49,603 Added 6.71%	788,739 $94.5 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $12.9 Million - $14 Million	122,538 Added 19.87%	739,136 $80.9 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $18.1 Million - $22 Million	197,485 Added 47.12%	616,598 $67.1 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $3.67 Million - $4.7 Million	47,950 Added 12.92%	419,113 $38.3 Million
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $194,616 - $284,582	-3,098 Reduced 0.83%	371,163 $29.3 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $1.83 Million - $2.03 Million	-23,268 Reduced 5.85%	374,261 $32.5 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $2.7 Million - $2.93 Million	-33,051 Reduced 7.68%	397,529 $33.3 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $531,440 - $619,820	7,292 Added 1.72%	430,580 $0
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $1.1 Million - $1.33 Million	-16,605 Reduced 3.77%	423,288 $0
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $2.17 Million - $2.46 Million	-33,141 Reduced 7.01%	439,893 $31.8 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $5.68 Million - $6.85 Million	93,342 Added 24.58%	473,034 $0
Q2 2018 Aug 09, 2018	BUY	$57.57 - $63.54 $13.7 Million - $15.2 Million	238,528 Added 168.97%	379,692 $0
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $7.6 Million - $8.59 Million	135,072 Added 2217.2%	141,164 $0
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $590 - $632	-11 Reduced 0.18%	6,092 $0
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $293,310 - $327,364	6,103	6,103 $326,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Abbott Laboratories Transaction History